InMode: Product Origination And Undervaluation Make The Stock A Buy

Company Performance - InMode Ltd reports impressive net income growth driven by the sale of non-invasive surgical products [1] - The company recently launched two new platforms, Define and Envision, which are expected to contribute to future business growth [1] Analyst Background - The analyst has nearly 14 years of experience in the financial industry, having worked for an equity research firm in NY, an investment fund in Mexico, and an investment bank in Ireland [1] - The analyst currently focuses on mature industries such as mining, oil and gas, and real estate, and targets investments with an internal rate of return of 5%-7% [1] - The analyst does not invest in business models they do not understand and appreciates M&A deals, deep value investments, and dividend investing [1] Disclosure - The analyst holds a beneficial long position in InMode Ltd through stock ownership, options, or other derivatives [2] - The article expresses the analyst's own opinions and they are not receiving compensation for it other than from Seeking Alpha [2] - The analyst has no business relationship with any company mentioned in the article [2]